Mark Levis, MD

Experts discuss the growing role of menin inhibitors in AML treatment, highlighting promising results from clinical trials. They explore the potential of menin inhibitors as standalone or combination therapy, focusing on their efficacy in specific AML mutations and the possibility of bridging patients to stem cell transplants.